Trisalus Life Sciences 8-K Filing: Stock & Warrant Insights (Jan 2025)

Here are the key insights extracted from the provided financial report section:

1. Entity Information:

• Company Name: Trisalus Life Sciences, Inc.
• CIK Number: 0001826667
• SEC File Type: 8-K
• Date of Filing: January 4, 2025
• Business Address: 6272 W. 91st Ave. Westminster, CO 80031
• Phone Number: 888-321-5212

2. Stock Information:

• Common Stock:
• • Par Value: $0.0001 per share
  • Ticker Symbol: TLSI (listed on NASDAQ)
• Warrants:
• • Each whole warrant is exercisable for one share of Common Stock.
  • Exercise Price: $11.50 per share
  • Ticker Symbol for Warrants: TLSIW (listed on NASDAQ)

3. Financial Context:

• The report references specific financial contexts for two classes of stock:
• • Common Stock
  • Warrants
• Both classes are recorded under the same reporting period, which is January 4, 2025.

4. Units of Measurement:

• The financial metrics are reported in:
• • USD (U.S. Dollars)
  • Shares

5. Regulatory References:

• The filing adheres to the US GAAP (Generally Accepted Accounting Principles) standards as indicated by the use of US GAAP dimensions for stock classes.

Summary:

This section of the financial report provides a snapshot of Trisalus Life Sciences, Inc.'s current stock and warrant offerings, their respective values, and regulatory compliance with SEC reporting standards. The common stock has a minimal par value, while the warrants are positioned at an exercise price of $11.50, indicating potential future dilution or financing opportunities. The details suggest a structured approach to communicating financial instruments to investors and stakeholders.